← FDA DRUG APPROVALS

FDA NDA · NDA014474

MEPROBAMATE

Sponsor: STANLABS PHARM

APPLICATION
NDA014474
TYPE
NDA
LATEST ACTION
1979-04-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MEPROBAMATEDiscontinued
MEPROBAMATE 400MG · TABLET · ORAL
MEPROBAMATEDiscontinued
MEPROBAMATE 200MG · TABLET · ORAL

Approval history

1979-04-30Labeling · Supplement 18AP
1979-04-04Labeling · Supplement 19AP
1978-05-15Labeling · Supplement 17AP
1977-01-26Manufacturing (CMC) · Supplement 15AP
1977-01-26Labeling · Supplement 16AP
1977-01-26Manufacturing (CMC) · Supplement 12AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →